{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:54:53Z","timestamp":1792101293929,"version":"4.4.0"},"reference-count":111,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>During its fourth transporter workshop in 2021, the International Transporter Consortium (ITC) provided updates on emerging clinically relevant transporters for drug development. Previously highlighted and new transporters were considered based on up\u2010to\u2010date clinical evidence of their importance in drug\u2013drug interactions and potential for altered drug efficacy and safety, including drug\u2013nutrient interactions leading to nutrient deficiencies. For the first time, folate transport pathways (PCFT, RFC, and FR\u03b1) were examined in\u2010depth as a potential mechanism of drug\u2010induced folate deficiency and related toxicities (e.g., neural tube defects and megaloblastic anemia). However, routine toxicology studies conducted in support of drug development appear sufficient to flag such folate deficiency toxicities, whereas prospective prediction from <jats:italic>in vitro<\/jats:italic> folate metabolism and transport inhibition is not well enough established to inform drug development. Previous suggestion of a retrospective study of intestinal OATP2B1 inhibition to explain unexpected decreases in drug exposure were updated. Furthermore, when the absorption of a new molecular entity is more rapid and extensive than can be explained by passive permeability, evaluation of the OATP2B1 transport may be considered. Emerging research on hepatic and renal OAT2 is summarized, but current understanding of the importance of OAT2 was deemed insufficient to justify specific consideration for drug development. Hepatic, renal, and intestinal MRPs (MRP2, MRP3, and MRP4) were revisited. MRPs may be considered when they are suspected to be the major determinant of drug disposition (e.g., direct glucuronide conjugates); MRP2 inhibition as a mechanistic explanation for drug\u2010induced hyperbilirubinemia remains justified. There were no major changes in recommendations from previous ITC whitepapers.<\/jats:p>","DOI":"10.1002\/cpt.2644","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T16:04:50Z","timestamp":1652457890000},"page":"485-500","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance"],"prefix":"10.1111","volume":"112","author":[{"given":"Maciej J.","family":"Zamek\u2010Gliszczynski","sequence":"first","affiliation":[{"name":"Drug Metabolism and PK GlaxoSmithKline  Collegeville Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sangha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto, Leslie Dan Faculty of Pharmacy  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[{"name":"Drug Metabolism and PK Bristol Myers Squibb Company  Princeton New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[{"name":"Drug Metabolism and PK Vertex Pharmaceuticals, Inc.  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1359-4795","authenticated-orcid":false,"given":"Matthias B.","family":"Wittwer","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann\u2010La Roche Ltd.  Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-6329","authenticated-orcid":false,"given":"Manthena V. S.","family":"Varma","sequence":"additional","affiliation":[{"name":"PK, Dynamics and Metabolism, Medicine Design Worldwide R&amp;D, Pfizer Inc.  Groton Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8167-4634","authenticated-orcid":false,"given":"Xiaomin","family":"Liang","sequence":"additional","affiliation":[{"name":"Drug Metabolism Gilead Sciences, Inc.  Foster City California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-8835","authenticated-orcid":false,"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Laboratory of Quantitative System PK\/Pharmacodynamics, School of Pharmacy, Kioicho Campus Josai International University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-3162","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research US Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto, Leslie Dan Faculty of Pharmacy  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International Transporter Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"e_1_2_11_1_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1112"},{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2020.02.004"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2004.tb00070.x"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20746"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-020911-153251"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00340-6"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409000969"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080711"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102353"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3123"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807665200"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05095.x"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067103"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103771"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2009.11.017"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-077099"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043160"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws122"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2004.tb00451.x"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991148"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.175"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1907077116"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000239RR"},{"key":"e_1_2_11_24_1","unstructured":"Ryan B.Dolutegravir use at conception not tied to neural tube defects after all. <https:\/\/www.poz.com\/article\/dolutegravir\u2010use\u2010conception\u2010tied\u2010neural\u2010tube\u2010defects> (2020). Accessed November 7 2021."},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807653"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905230"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30268-X"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002741"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002719"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002289"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103167"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.1635"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.087635"},{"key":"e_1_2_11_34_1","unstructured":"Depakote ER (divalproex sodium) Tablet.NDA 021168\/S\u2010016\/S\u2010017\/S\u2010020\/S\u2010022(2011)."},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420520506"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0283"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20318"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23277"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14078"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14721"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.19072"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1508861"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22229"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.5858\/1999-123-0774-IMIMAI"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-6-780"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.001"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.051300"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.072397"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.004"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.12.009"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.087619"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.084483"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011408612"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21618"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13159"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.03.010"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2021.100416"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3028"},{"key":"e_1_2_11_59_1","unstructured":"FDA Guidance for Industry: In vitro drug interaction studies \u2014 cytochrome P450 enzyme\u2010 and transporter\u2010mediated drug interactions(2020). <https:\/\/www.fda.gov\/media\/134582\/download>. Accessed November 7 2021."},{"key":"e_1_2_11_60_1","first-page":"488","article-title":"Clinically relevant OATP2B1 inhibitors in marketed drug space","volume":"17","author":"Unger M.S.","year":"2020","journal-title":"Mol. Pharm."},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1920483117"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2020.1745318"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.0c03930"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12672"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.090316"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.2.804"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00747"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834300cc"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.713567"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.45"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.34"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.072264"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.043117"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.062364"},{"key":"e_1_2_11_75_1","first-page":"281","article-title":"Obsessive\u2013compulsive disorder in Tourette's syndrome","volume":"65","author":"Como P.G.","year":"1995","journal-title":"Adv. Neurol."},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.66"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12508"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.074294"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199803010-00007"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.5.804"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.257600"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201500433"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00320"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b01108"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.245951"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.252049"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000425"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00612.x"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00216"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.10.015"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.74"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.055558"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.043"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000230422.50962.91"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-12-RG-068"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.08.012"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0792-7"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502530102"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.03.027"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.207472"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012080857"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.48"},{"key":"e_1_2_11_103_1","first-page":"188","article-title":"Dubin\u2010Johnson syndrome","volume":"18","author":"Nisa A.U.","year":"2008","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1222"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfx060"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kft176"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.054304"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.4162\/nrp.2007.1.3.163"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S130050"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.01.003"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006287024"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2644","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.2644","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:31:31Z","timestamp":1699363891000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.2644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/cpt.2644"],"URL":"https:\/\/doi.org\/10.1002\/cpt.2644","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}